NCT04076059 2026-04-17China ARCHESAstellas Pharma IncPhase 3 Active not recruiting180 enrolled 24 charts
NCT02489318 2026-04-13TITANAragon Pharmaceuticals, Inc.Phase 3 Active not recruiting1,052 enrolled 13 charts 2 FDA
NCT04108208 2026-04-13A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)Janssen Research & Development, LLCPhase 4 Active not recruiting75 enrolled 9 charts
NCT03419234 2026-04-01Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelEastern Cooperative Oncology GroupPhase 2 Active not recruiting223 enrolled 14 charts
NCT04191096 2026-03-20KEYNOTE-991Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,251 enrolled 15 charts